Sugi Predict

Sugi Predict / Compounds / SCHEMBL4981005

SCHEMBL4981005

SCHEMBL4981005

C=CCc1c(CO)cccc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.48
▸ KDM4E B2RXH2 4/20 0.48
▸ GAA P10253 1/20 0.48
▸ ELANE P08246 1/20 0.43
▸ HPGD P15428 1/20 0.42
▸ POLB P06746 2/20 0.42
▸ CYP3A4 P08684 1/20 0.41
▸ ALOX5 P09917 1/20 0.41
▸ AR P10275 1/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ TRPM8 Q7Z2W7 1/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ PPARG P37231 1/20 0.41
▸ PPARD Q03181 1/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ GABRA1 P14867 1/20 0.40
▸ GABRB2 P47870 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18984961 0.88 ALDH1A1 (0.48) ALDH1A1KDM4EGAAELANEHPGD
SCHEMBL2845228 0.84 ALDH1A1 (0.53) ALDH1A1KDM4EGAAELANEHPGD
SCHEMBL1029593 0.82 PDE4A (0.45) ALDH1A1KDM4EHPGDCYP3A4ALOX5
SCHEMBL6390934 0.81 HSD17B10 (0.44) ALDH1A1KDM4EGAAELANEHPGD
SCHEMBL19860989 0.80 ALDH1A1 (0.39) ALDH1A1KDM4EGAAELANEHPGD
SCHEMBL27569149 0.80 PTGS2 (0.51) ALDH1A1KDM4EGAAELANEHPGD
SCHEMBL2479613 0.79 ALDH1A1 (0.52) ALDH1A1KDM4EGAAELANEHPGD
SCHEMBL16954472 0.79 ALOX5 (0.45) ALDH1A1KDM4EHPGDCYP3A4ALOX5
SCHEMBL616173 0.78 GABRA1 (0.52) ALDH1A1KDM4EGAAPOLBKMT2A
SCHEMBL8135903 0.77 PDE4A (0.41) ALDH1A1KDM4EHPGDCYP3A4ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11724979-B2 Process for the preparation of treprostinil CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. (HU) 2023-08-15 — — US disclosed
US-11724979-B2 Process for the preparation of treprostinil CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. (HU) 2023-08-15 — — US disclosed
US-20210340093-A1 PROCESS FOR THE PREPARATION OF TREPROSTINIL CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. (HU) 2021-11-04 — — US disclosed
EP-3398931-B1 METHODS OF SYNTHESIZING A PROSTACYCLIN ANALOG CAYMAN CHEMICAL CO INC (US) 2020-04-08 — — EP disclosed
CN-110590547-A Method for synthesizing prostacyclin derivative 开曼化学股份有限公司 2019-12-20 — — CN disclosed
US-10450257-B2 Methods of synthesizing a prostacyclin analog CAYMAN CHEMICAL COMPANY INCORPORATED (US) 2019-10-22 — — US disclosed
US-10450257-B2 Methods of synthesizing a prostacyclin analog CAYMAN CHEMICAL COMPANY INCORPORATED (US) 2019-10-22 — — US disclosed
US-20190248725-A1 PROCESS FOR THE PREPARATION OF TREPROSTINIL CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. (HU) 2019-08-15 — — US disclosed
US-10155716-B2 Amine salts of a prostacyclin analog CAYMAN CHEMICAL COMPANY INCORPORATED (US) 2018-12-18 — — US disclosed
EP-3398931-A1 METHODS OF SYNTHESIZING A PROSTACYCLIN ALALOG Cayman Chemical Company, Incorporated (US) 2018-11-07 — — EP disclosed
EP-2928858-A2 METHODS OF SYNTHESIZING A PROSTACYCLIN ANALOG Cayman Chemical Company, Incorporated (US) 2015-10-14 — — EP disclosed
WO-2015073314-A1 AMINE SALTS OF A PROSTACYCLIN ANALOG CAYMAN CHEMICAL COMPANY INCORPORATED (US) 2015-05-21 — — WO disclosed
WO-2015073314-A1 AMINE SALTS OF A PROSTACYCLIN ANALOG CAYMAN CHEMICAL COMPANY INCORPORATED (US) 2015-05-21 — — WO disclosed
WO-2014089385-A2 METHODS OF SYNTHESIZING A PROSTACYCLIN ANALOG CAYMAN CHEMICAL COMPANY INCORPORATED (US) 2014-06-12 — — WO disclosed
WO-2014089385-A2 METHODS OF SYNTHESIZING A PROSTACYCLIN ANALOG CAYMAN CHEMICAL COMPANY INCORPORATED (US) 2014-06-12 — — WO disclosed
US-20080119518-A1 1-(Piperidin-4- Yl)-1H-Indole Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-05-22 — — US disclosed
US-20080119518-A1 1-(Piperidin-4- Yl)-1H-Indole Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-05-22 — — US disclosed
US-20080119518-A1 1-(Piperidin-4- Yl)-1H-Indole Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-05-22 — — US disclosed
EP-1847535-A1 1-(PIPERIDIN-4-YL)-1H-INDOLE DERIVATIVE Eisai R&D Management Co., Ltd. (JP) 2007-10-24 — — EP disclosed
EP-1847535-A1 1-(PIPERIDIN-4-YL)-1H-INDOLE DERIVATIVE Eisai R&D Management Co., Ltd. (JP) 2007-10-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119518-A1 1-(Piperidin-4- Yl)-1H-Indole Derivatives TPH1, HTR1D, HTR1B ALDH1A1 91/4885KDM4E 1637/4885GAA 4739/4885
US-11724979-B2 Process for the preparation of treprostinil PTGIS, TFPI, TREH ALDH1A1 1547/4885KDM4E 4352/4885GAA 564/4885
US-20190248725-A1 PROCESS FOR THE PREPARATION OF TREPROSTINIL PTGIS, TFPI, TREH ALDH1A1 1547/4885KDM4E 4352/4885GAA 564/4885
US-10155716-B2 Amine salts of a prostacyclin analog PTGIS, PTGIR, PTGER1 ALDH1A1 519/4885KDM4E 3962/4885GAA 4379/4885
US-10450257-B2 Methods of synthesizing a prostacyclin analog PTGIS, CYP11B1, CYP11B2 ALDH1A1 282/4885KDM4E 4304/4885GAA 3529/4885
US-20210340093-A1 PROCESS FOR THE PREPARATION OF TREPROSTINIL PTGIS, TFPI, TREH ALDH1A1 1547/4885KDM4E 4352/4885GAA 564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.